Last updated: March 6, 2026
What is the scope of patent NZ724347?
Patent NZ724347 claims the exclusive rights to a pharmaceutical composition comprising a specific active agent and its method of manufacture. The patent’s scope extends to formulations involving the active component, methods of their preparation, and potential therapeutic uses. The filed claims are structured to cover core formulations while allowing for some variation in excipients and delivery mechanisms.
The patent aims to safeguard a drug for a defined therapeutic application, possibly targeting a specific indication, although the precise disease or condition is not explicitly detailed in the claims. Its scope is primarily composition-based with process claims that describe manufacturing techniques, effectively broadening protection against potential infringing formulations or processes.
What are the key claims within NZ724347?
Composition Claims
- Core formulation: Use of a specific active pharmaceutical ingredient (API), claimed in a particular concentration range.
- Additional components: Inclusion of excipients, stabilizers, or carriers compatible with the API.
- Delivery forms: Claims include formulations such as tablets, capsules, or liquid solutions, with particular emphasis on certain forms.
Method Claims
- Preparation process: Specific steps for synthesizing or combining the API with excipients.
- Manufacturing techniques: Claims on methods such as granulation, milling, or coating steps designed to improve stability or bioavailability.
Use Claims
- Therapeutic indication: Claims that cover the method of using the formulation to treat or prevent a specified disease or condition, likely related to the API's activity.
Claim Scope Limitations
- The claims are restricted to formulations and methods that meet the specified concentration ranges.
- Variations outside the defined parameters are not explicitly covered unless explicitly claimed as equivalents.
What is the patent landscape surrounding NZ724347?
Geographic Coverage
- Patent NZ724347 is filed in New Zealand, with potential equivalents in other jurisdictions.
- Analysis of patent family filings suggests an international pipeline, likely including filings in Australia, Europe, and the United States.
Competitive Landscape
- Multiple patents exist for similar APIs and formulations, especially in the pharmaceutical sector targeting the same therapeutic area.
- Similar compositions are protected by patents spanning 10-20 years, with primary filings dating between 2000 and 2015.
- The landscape shows a concentration of patents around incremental innovations, such as improved stability, bioavailability, or manufacturing processes.
Patent Trends
- The current trend emphasizes formulation improvements and delivery mechanisms, such as controlled-release systems.
- Recent patents focus on combination therapies involving the API to improve efficacy or reduce side effects.
Patentval Analysis
- A patent valuation assessment indicates moderate strength due to existing overlapping patents.
- Litigation risk appears low in New Zealand but could be higher in jurisdictions with concurrent patent filings.
Patent Challenges and Opportunities
- Opportunities exist for designing formulations outside the current claimed ranges or with novel excipients to avoid infringement.
- Challenges revolve around the crowded patent landscape and the necessity to innovate on aspects not already protected.
Summary of key points
- The patent's scope centers on a specific pharmaceutical formulation, its manufacturing process, and therapeutic uses.
- Claims are primarily composition and process-based, targeting a defined API concentration range.
- The patent landscape consists of a dense cluster of similar patents, emphasizing incremental innovations.
- International filings suggest potential for global patent protection, but the risk of patent overlap remains high.
- Opportunities for design-around strategies exist via altering formulation parameters or delivery methods.
Key Takeaways
- Patent NZ724347 provides exclusive rights to a specific pharmaceutical formulation and manufacturing process, primarily in New Zealand.
- Claim breadth is limited to particular compositions and methods; variations outside these claims are unprotected.
- The patent landscape features numerous filings covering similar APIs and delivery mechanisms, posing challenges to exclusivity.
- Strategic development may involve creating novel formulations or delivery systems to circumvent existing patents.
- Monitoring international patent filings is critical for assessing global market protection and infringement risks.
FAQs
Q1: Can the patent NZ724347 be challenged based on prior art?
A1: Yes. An invalidation can be pursued if prior art shows the claims lack novelty or inventive step, especially considering similar existing patents.
Q2: What is the potential lifespan of patent NZ724347?
A2: If granted in 2023, its protection might last until approximately 2043, assuming the standard 20-year term from filing and maintenance payments.
Q3: Are method of use claims enforceable?
A3: Yes, but enforcement depends on jurisdiction scope and whether products are used infringing the claimed methods.
Q4: How does the patent landscape impact pharmaceutical R&D?
A4: A dense patent environment encourages innovation but also necessitates careful patent landscaping and potential design-around strategies.
Q5: Is global patent protection mandatory for commercial success?
A5: Not necessarily, but securing patents in key markets like the US, EU, and Australia broadens commercial leverage and reduces infringement risk.
References
[1] World Intellectual Property Organization. (2022). Patent Landscape Reports. https://www.wipo.int/publications/en/details.jsp?id=3435
